Pharmacokinetics and Safety of Elotuzumab Combined With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma and Various Levels of Renal Impairment: Results of a Phase Ib Study

Authors:
Open Access
Publisher website
Google Scholar
Abstract
No abstract available
Funding Information
  • Bristol-Myers Squibb

This publication has 26 references indexed in Scilit: